IGMPI India



Parabolic Drugs obtains European GMP certification

Parabolic Drugs announced that the company has received European GMP certification for its Derabassi and Lalru plant. The worksite located at Derabassi is engaged in manufacturing of Cephalosporin products (Certificate No. DE_RP_01_ GMP_2014_0023) and the plant located in Lalru is engaged in manufacturing of Non-beta Lactams products (Certificate No. DE_RP_01_ GMP_2014_0024).

Parabolic Drugs (PDL) has started its commercial operations in 1998 with contract manufacturing of APIs and API intermediates for sales in India and abroad (including regulated markets). At present, Parabolic Drugs has four facilities consisting of three manufacturing plants i.e. Derabassi, Chachrauli (both Punjab) and Panchkula and a Research & Development centre at Barwala (both Haryana).